Skip to main content
. Author manuscript; available in PMC: 2016 Jan 2.
Published in final edited form as: Circ Res. 2015 Jan 2;116(1):12–15. doi: 10.1161/CIRCRESAHA.114.305495

Figure 1.

Figure 1

Mesenchymal stem cells are considered immunoprivileged due to their lack of expression of Major Histocompatibility Class II proteins and costimulatory molecules B7 and CD40 ligand and exert immunosuppressive actions through inhibition of innate and adaptive immunity.